Abstract:Background: MYH9-related diseases (MYH9-RD) are autosomal dominant disorders caused by mutations of the MYH9 gene encoding the non-muscle myosin heavy chain IIA. They are characterized by congenital thrombocytopenia, giant platelets and leucocyte inclusions. Hearing impairment, pre-senile cataract and nephropathy can also occur. We aimed to evaluate renal involvement and outcome in MYH9-RD patients followed-up by nephrologists. Methods: We conducted a retrospective multicentre observational study of 13 patients among 9 families with MYH9 mutation diagnosed by genetic testing and immunofluorescence assay referred to nephrologists. Results: At initial referral, median age was 30 (range 14-76) years. Median estimated glomerular filtration rate was 66 mL/min/1.73 m2 (0-141) and two patients had already end-stage renal disease (ESRD). Renal presentation associated proteinuria (n = 12), haematuria (n = 6) and hypertension (n = 6). Three patients developed a rapid onset ESRD whereas five others had a relatively stable kidney function over a 3-year median follow-up (1-34). Extra-renal features varied widely, with hearing impairment in six patients, cataract in two and mild liver dysfunction in seven. Thrombocytopenia existed at referral in 11 patients. Time to diagnosis varied from 0 to 29 years (median 3 years). Initial diagnoses such as idiopathic thrombocytopenic purpura (n = 4) and focal segmental glomerulosclerosis (n = 1) led to corticosteroid administration (n = 4), intravenous immunoglobulins (n = 3), cyclophosphamide (n = 1) and splenectomy (n = 1). Conclusions: Renal involvement and outcome in MYH9-RD are heterogeneous. The diagnosis is often delayed and misdiagnoses can lead to unnecessary treatments. MYH9-RD should be considered in any patient with glomerular involvement associated with a low or slightly decreased platelet count and/or hearing loss and liver dysfunction.

[Hereditary sensorineural hearing impairment and macrothrombocytopenia: a rare MYH9 gene mutation]

Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia

[Hereditary macrothrombocytopenia and hearing loss]

Hereditary thrombocytopenia with familial novel mutation in MYH9 gene: A familial case report

Homocystinuria In A Family With Novel Cystathionine Beta Synthase Gene Mutations

[Case of an hemodialysis patient with MYH9 disorders]

MYH9-related disorders: report on a patient of Greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation

Case Report: Pathogenic MYH9 c.5797delC Mutation in a Patient With Apparent Thrombocytopenia and Nephropathy

Genotype-phenotype correlation in MYH9-related thrombocytopenia

Renal manifestations of patients with MYH9-related disorders

A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia

[Hereditary thrombocytopenia associated with a mutation in the MYH-9 gene. Report of one case]

Linking the Landscape of MYH9-Related Diseases to the Molecular Mechanisms that Control Non-Muscle Myosin II-A Function in Cells

[Nonmuscle Myosin Heavy Chain 9 Gene Mutations Related Disease: a Family Report].

A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature

Unusual Cause of Thrombocytopenia and Renal Failure in a 14-Year-Old Boy (MYH9-Associated Disorders)

MYH9-related disorder with sole presentation of end-stage kidney disease and long-term, recurrence-free living after living donor renal transplantation: a case report

MYH9-related disorders display heterogeneous kidney involvement and outcome

Hereditary nephritis with macrothrombocytopenia: phenotypic variety and the genotypic defect

[Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders]

A novel MYH9 mutation related to non-syndromic delayed post-lingual sensorineural hearing loss